2016 - Present | Radiation Oncologist, Baptist Health South Florida ‐ Miami Cancer Institute | |
|
||
2013 - 2016 | Medical Director Provision Center for Proton Therapy, Radiation Oncology, Knoxville, TN, Provision Center for Proton Therapy | |
|
||
2011 - 2013 | Medical Staff, ProCure Oklahoma City Proton Therapy Center ‐ Oklahoma Proton Radiation Therapy Group | |
|
||
2007 - 2011 | Medical Staff, Missouri Baptist Medical Center | |
|
||
1996 - 2007 | Medical Director, Radioterapica do RGS, Porto Alegre, Brazil | |
|
Disciplines
Research Interests
Grants
2016 - Present | Pragmatic Phase III Randomized Trial of Proton vs Photon Therapy for Patients with non-metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RACOMP) |
Abramson Cancer Center of the University of Pennsylvania - NCT02603341 | |
Role: Site Contact. Miami Cancer Institute | |
2014 - Present | A Phase II Study of Hypofractionated Image Guided Proton Therapy for Low and Intermediate Risk Prostate Cancer |
Provision Center for Proton Therapy - NCT02040610 | |
2014 - Present | Randomized Phase II Trial of Hypofracionated Dose-Escalation Photon IMRT or Proton Beam Therapy vs Conventional Photon Irradiation with Concomitant and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma |
NRG Oncology - NCT02179086 | |
Role: Sub-Investigator | |
2012 - Present | Prostate Advanced Radiation Technologies Investigating Quality of Life PARTIQoL: A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer |
Massachusetts General Hospital - NCT01617161 | |
Role: Co-Principal Investigator | |
2010 - 2020 | Retreatment of Recurrent Tumors Using Proton Therapy |
Abramson Cancer Center of the University of Pennsylvania - NCT01126476 | |
Retreatment of Recurrent Tumors Using Proton Therapy | |
Role: Site Principal Investigator, ProCure, Oklahoma City, OK | |
2012 - 2018 | RTOG 1205: Randomized Phase II Trial of Concurrent Bevazizumab and Re-irradiation vs Bevacizumab alone as treatment for Recurrent Glioblastoma (open to accrual at Provision Proton Center |
Radiation Therapy Oncology Group - NCT01730950 | |
Role: Sub-Investigator | |
2009 - 2017 | A Pilot Study Using Neoadjuvant Proton Beam Radiation Therapy and Chemotherapy for Resectable Carcinoma of the Pancreas |
University of Florida - NCT00763516 | |
Role: Sub-Investigator, Institutional PI | |
2013 - 2016 | A Phase II Trial of Postoperative Proton Therapy with Concurrent Chemotherapy for Patients with Resected Pancreatic Adenocarcinoma |
Provision Proton Center | |
Role: Sub-Investigator, Institutional PI | |
2013 - 2016 | Multi-Institutional Registry and Treatment Outcomes Trial |
Provision Center for Proton Therapy | |
Role: Role: Principal Investigator, between opening to accrual |
Professional Service and Affiliations
2013 - Present | Member, Particle Therapy Cooperative Group - North America (PTCOG-NA) | 1994 - Present | Member, American Society for Therapeutic Radiology and Oncology (ASTRO) |
Courses
- 2019 - Present Associate Professor FIU Herbert Wertheim College of Medicine 1994
- 1994-1996 Assistant Professor in Radiation Oncology TUFTS University New England Medi
1993 - 1994 | Clinical Fellowship, Radiation Oncology, Harvard School of Medicine, Massachusetts General Hospital, Boston, MA | |
|
||
1990 - 1993 | Residency, Radiation Oncology, University of Miami, Jackson Memorial Hospital/Sylvester Cancer Center, Miami, FL | |
|
||
1989 - 1990 | Internship, General Medicine, University of Miami, Jackson Memorial Hospital, Miami, FL | |
|
||
1988 - 1989 | Clinical volunteer clerkship, Radiation Oncology, Centro de Oncologia Radioterapica do RGS, Brazil | |
|
||
1982 - 1988 | Doctor of Medicine, Universidade Federal do RGS, Porto Alegre, Brazil | |
|
Links
Contact Information
Miami Cancer Institute
8900 N. Kendall Drive
Miami, FL 33176
(786) 596-2000